New reports are described each year on the occurrence of human metabolic diseases due to specific enzyme deficiencies (Harris, 1970; McKusick, 1971) . For the biomedical scientist interested either in the mode of genetic transmission of these biochemical traits or in the mammalian control mechanisms of gene-enzyme expression it would be desirable to be able to supplement the research on human beings with investigations on appropriate animal models. With regard to human hyperprolinaemia two variants of this metabolic disorder have been described (Efron, 1966 Previously in this laboratory we reported on the discovery of an unusual biochemical trait occurring in the PRO/Re inbred strain ofmice, namely a marked hyperprolinaemia and concomitant prolinuria (Blake & Russell, 1972) . Since the proline concentration was elevated in both the blood and the urine, the possibility of an enzyme defect in the liver was considered. The present communication describes the finding of a markedly decreased proline oxidase activity in the liver of PRO/Re mice. Proline oxidase activity was also measured in the livers of C57BL/6J, 129/ReJ, Vol. 129 DBA/2J and ST/bJ inbred strains of mice and in the F1 hybrid (PRO/Re x ST/bJ).
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(Received 13 July 1972) New reports are described each year on the occurrence of human metabolic diseases due to specific enzyme deficiencies (Harris, 1970; McKusick, 1971) . For the biomedical scientist interested either in the mode of genetic transmission of these biochemical traits or in the mammalian control mechanisms of gene-enzyme expression it would be desirable to be able to supplement the research on human beings with investigations on appropriate animal models. With regard to human hyperprolinaemia two variants of this metabolic disorder have been described (Efron, 1966) . Shafter et al. (1962) reported a familial hyperprolinaemia associated with cerebral dysfunction and renal anomalies occurring in a family with hereditary nephropathy and deafness. A second case of familial hyperprolinaemia, reported by Efron (1965) , was associated with congenital renal malformation, hereditary haematuria and mild mental retardation. The metabolic disorder in the second case was further associated with a deficiency of liver proline oxidase activity. Hyperprolinaemia caused by a deficiency of liver proline oxidase activity has been classified (Efron, 1966) as type I hyperprolinaemia (Scheme 1). Efron (1966) Previously in this laboratory we reported on the discovery of an unusual biochemical trait occurring in the PRO/Re inbred strain ofmice, namely a marked hyperprolinaemia and concomitant prolinuria (Blake & Russell, 1972) . Since the proline concentration was elevated in both the blood and the urine, the possibility of an enzyme defect in the liver was considered. The present communication describes the finding of a markedly decreased proline oxidase activity in the liver of PRO/Re mice. Proline oxidase activity was also measured in the livers of C57BL/6J, 129/ReJ, Vol. 129 DBA/2J and ST/bJ inbred strains of mice and in the F1 hybrid (PRO/Re x ST/bJ).
Proline oxidase was isolated from liver and assayed by the method of Strecker (1971) . Livers were homogenized in 0.25M-sucrose, pH7.4, containing 1 mm-EDTA with Thomas tissue grinders of the Teflonpestle model (3431-E20) at a 1:9 (w/v) ratio of tissue to sucrose solution. The homogenate was centrifuged at 2000rev./min (480g) for 10min in an SS-34 rotor of the Sorvall RC-2 refrigerated centrifuge. The S-1 supernatant fluid, derived from the first centrifugation, was centrifuged at 9200 rev./min (lOOOOg) for 10min. The S-2 supernatant fluid was centrifuged at 9200rev./min for 10min. The pellets P-2 and P-3 were combined and resuspended in the 0.25 M-sucrose solution to approx. 0.4 times the volume of the original homogenate. This suspension was centrifuged at 12000rev./min (17300g) for 10min to form a firm pellet. After the supematant fluid had been decanted off, the pellet was stored overnight at -30°C. Immediately before assay for proline oxidase activity, the pellet was thawed, suspended in 2vol. (per g wet wt. of whole liver) of the sucrose-EDTA solution and homogenized in the Thomas tissue grinder. This homogenate was utilized directly for enzyme activity measurements. Protein concentration was determined by the biuret method of Layne (1957) .
The results presented in Table 1 compare the liver proline oxidase activity in the mitochondrial preparations of PRO/Re mice with that of several other inbred strains including the two original parental lines, the C57BL/6J and 129/ReJ mice (Blake & Russell, 1972) . The specific activity of liver proline oxidase in the mitochondrial preparations of PRO/Re mice averaged about 0.4 enzyme unit/mg of protein. The liver proline oxidase activity of PRO/Re mice was assayed in amounts varying from 0.1 to 1.Oml of the mitochondrial homogenate. In the C57BL/6J and 129/ReJ mice, enzyme activity was approx. 25-30 times as high, averaging about 9.3 and 11.3 units/mg of mitochondrial protein respectively. Similar enzyme activities were also determined in the ST/bJ and DBA/2J mice, although the activity was slightly higher in the DBA/2J strain.
For determination of proline oxidase activity in an F1 hybrid, PRO/Re mice were bred with ST/bJ mice. Comparative studies were also undertaken between the PRO/Re and ST/bJ mice to determine whether the deficiency of proline oxidase activity occurred only in liver or was manifest in other tissues such as kidney and brain. We found that the proline oxidase activity was very low in both kidney and brain of PRO/Re mice. In the kidney proline oxidase activity of ST/bJ and PRO/Re mice was 13.8 and 0.03 units/mg of protein respectively. In the brain proline oxidase activity was 1.5 and 0.02 units/mg of protein for the ST/bJ and PRO/Re mice. Since proline oxidase activity is deficient in both the liver and the kidney as well as the brain of PRO/Re mice, this inbred strain may serve as an excellent animal model for studies on aminoacidurias and the development of biochemical defects causing mental retardation. The administration of proline to neonatal and young PRO/Re mice when their central nervous system is still in the process of development and maturation might cause severe and persisting behaviour abnormalities.
We have no evidence as yet on the mechanism by which proline oxidase deficiency occurs in PRO/Re mice. A number ofpossibilities exist of both the quantitative and qualitative mechanisms. A gene mutation might affect the turnover rate of the enzyme. Enzyme activity may be deficient because of a decrease in the number of enzyme molecules as a consequence of either a low rate of enzyme synthesis or an increased rate of degradation. Alternatively the enzyme population might be normal in quantity but the catalytic activity ofthe enzyme might bedefective. The PRO/Re strain should provide an excellent opportunity for the 1972 investigation of control mechanisms of mammalian enzyme regulation in a mutant bearing an inborn error of metabolism. With regard to the specificity of the enzyme defect we assayed livers of PRO/Re mice for Al-pyrroline-5-carboxylate dehydrogenase activity, since a defect in the regulation of this enzyme could also result in hyperprolinaemia. However, no significant differences were found between PRO/Re and C57BL/6J mice. Duplicate analyses demonstrated activities of 5.5 and 5.9 and of 5.6 and 5.8rnmol of Al-pyrroline-5-carboxylate oxidized/min per mg of protein at 25°C for PRO/Re and C57BL/6J mice respectively. Thus the inborn error of proline metabolism in PRO/Re mice appears to be specific for a deficiency of proline oxidase activity.
In summary, the hyperprolinaemia occurring in the highly inbred PRO/Re strain ofmice is associated with a marked deficiency of proline oxidase activity. Enzyme activity is deficient in liver, kidney and brain. F1 hybrid mice exhibit an intermediate liver proline oxidase activity. The PRO/Re strain may serve as an animal model for biomedical investigations on type I hyperprolinaemia.
